Although the aim of this work was not to study the impact of hepcidin values on outcome after HCT, nevertheless no negative impact of an elevated pre-transplant hepcidin concentration on outcome, the incidence or severity of acute or chronic GVHD, or early infectious complications after HCT could be detected in this cohort. Here, HAMP is linked to chronic graft versus host disease.